Real-world evidence now supports new indications and safety decisions, and AI increasingly generates it. Boards should know where their company relies on it, how well the design fits the question, and how its credibility is shown.

I listed ten precision healthcare trends in 2022. Some reached patients and some faded; the difference is the evidence path, and it is the test boards should apply to AI.